InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Verwiel Frank, Director. Officer active across 1 companies, notably Intellia Therapeutics, Inc.. Cumulatively, 3 reports have been logged. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
05,197 shares0
Common Stock
SEC:0001209191-22-037604:0·
02,094 shares0
Common Stock
SEC:0001209191-21-043385·
02,094 shares0
Common Stock
SEC:0001209191-21-043385:0·
3 of 3 declarations
About Verwiel Frank
Frank Verwiel is a Board Member at Intellia Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
